News & Resources

The Biden-Harris administration, through the U.S. Department of Commerce’s Economic Development Administration (EDA), announced yesterday that the Richmond-Petersburg MSA (the Region) has been designated as an Advanced Pharmaceutical Manufacturing (APM) Technology and Innovation Hub (Tech Hub).
Activation Capital, an innovation ecosystem development organization, today announced Governor Glenn Youngkin’s appointment of Garrison Coward and Donna Edmonds to the board of the Virginia Biotechnology Research Partnership Authority (dba Activation Capital).
Activation Capital, an innovation ecosystem development organization, announced plans to develop the 102,000-square foot Innovation Center in the Bio+Tech Park in Richmond, Virginia.
Activation Capital today announced the appointment of John Gerber & DJ Nordquist to the board of the Activation Capital.
Activation Capital, an innovation ecosystem development organization, today announced that it has received $15M in funding from the Commonwealth of Virginia to accelerate the development of Central Virginia's life sciences sector, including expanding regional capacity for end-to-end essential medicine research, development, and manufacturing.
The latest funding highlights a series of investments into the Virginia Bio+Tech Park, complementing the City of Richmond’s investment into its Innovation District vision.
The new operations role will help build critical organizational infrastructure to improve performance and achieve strategic goals during a growth phase.